evertex fabrinology limited - Laporan Laba Rugi (TTM)

evertex fabrinology limited
TW ˙ TWSE
NT$ 21.05 ↑1.30 (6.58%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi evertex fabrinology limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 647 631 626 773 858 895 993 968 951 845 777 717 637 655 613 651 702 788 812 824
Change (%) -2.53 -0.71 23.45 11.01 4.26 10.97 -2.54 -1.78 -11.09 -8.04 -7.70 -11.27 2.93 -6.37 6.06 7.84 12.31 3.01 1.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 514 517 524 626 683 704 768 744 738 671 624 583 520 525 488 506 534 589 615 624
Change (%) 0.64 1.28 19.53 9.10 3.03 9.09 -3.03 -0.83 -9.13 -6.99 -6.63 -10.83 1.13 -7.14 3.76 5.48 10.24 4.55 1.40
% of Revenue 79.40 81.98 83.63 80.97 79.58 78.64 77.30 76.91 77.66 79.37 80.28 81.21 81.61 80.19 79.53 77.81 76.11 74.70 75.82 75.75
Gross Operating Profit 133 114 103 147 175 191 225 223 212 174 153 135 117 130 126 144 168 199 196 200
Change (%) -14.74 -9.80 43.51 19.09 9.06 17.92 -0.86 -4.94 -17.93 -12.08 -12.07 -13.15 10.92 -3.29 15.01 16.11 18.92 -1.54 1.74
% of Revenue 20.60 18.02 16.37 19.03 20.42 21.36 22.70 23.09 22.34 20.63 19.72 18.79 18.39 19.81 20.47 22.19 23.89 25.30 24.18 24.25
SG&A 105 96 92 107 115 113 120 113 108 106 100 97 92 96 94 101 106 112 114 113
Change (%) -8.83 -3.52 16.19 7.81 -2.47 6.40 -5.76 -4.16 -2.15 -5.38 -3.60 -4.38 4.40 -2.25 6.74 5.07 5.93 2.02 -1.11
% of Revenue 16.20 15.15 14.72 13.86 13.46 12.59 12.07 11.67 11.39 12.54 12.90 13.47 14.52 14.72 15.37 15.47 15.07 14.21 14.08 13.72
R&D
Change (%)
% of Revenue
OpEx 619 613 616 733 798 816 887 857 846 777 724 679 612 622 582 607 640 701 730 737
Change (%) -0.96 0.53 19.03 8.92 2.24 8.72 -3.40 -1.27 -8.23 -6.77 -6.21 -9.91 1.62 -6.38 4.24 5.41 9.52 4.14 1.02
% of Revenue 95.60 97.13 98.35 94.82 93.04 91.23 89.37 88.58 89.04 91.91 93.18 94.69 96.13 94.91 94.91 93.28 91.18 88.91 89.89 89.49
Operating Income 28 18 10 40 60 78 106 110 104 68 53 38 25 33 31 44 62 87 82 87
Change (%) -36.48 -42.93 287.28 49.30 31.35 34.47 4.69 -5.73 -34.34 -22.47 -28.08 -35.38 35.35 -6.28 39.98 41.51 41.12 -6.11 5.58
% of Revenue 4.40 2.87 1.65 5.18 6.96 8.77 10.63 11.42 10.96 8.09 6.82 5.31 3.87 5.09 5.09 6.72 8.82 11.09 10.11 10.51
Interest Expense -1 -1 -1 -1 -0 -0 -0 -0 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Change (%) -4.99 -5.25 -4.21 -2.40 -2.04 -2.09 1.92 6.28 9.65 12.75 12.58 13.01 12.64 6.78 4.06 -0.70 -4.53 -2.95 -3.48
% of Revenue -0.09 -0.09 -0.08 -0.06 -0.06 -0.05 -0.05 -0.05 -0.05 -0.07 -0.08 -0.10 -0.13 -0.14 -0.16 -0.15 -0.14 -0.12 -0.11 -0.11
Net Income 32 35 25 63 67 65 86 50 50 33 41 56 49 49 45 60 66 97 86 49
Change (%) 11.83 -30.46 157.09 5.15 -2.07 31.29 -41.48 -0.28 -34.26 25.54 35.41 -12.75 1.30 -8.52 32.99 9.71 47.75 -11.73 -43.17
% of Revenue 4.89 5.61 3.93 8.19 7.76 7.29 8.62 5.18 5.26 3.89 5.30 7.78 7.65 7.53 7.36 9.23 9.39 12.35 10.58 5.93

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista